Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Revenue (2020 - 2025)

Insight Molecular Diagnostics' Revenue history spans 6 years, with the latest figure at $260000.0 for Q3 2025.

  • For Q3 2025, Revenue rose 126.09% year-over-year to $260000.0; the TTM value through Sep 2025 reached $4.4 million, up 520.87%, while the annual FY2024 figure was $1.9 million, 25.15% up from the prior year.
  • Revenue for Q3 2025 was $260000.0 at Insight Molecular Diagnostics, down from $518000.0 in the prior quarter.
  • Across five years, Revenue topped out at $2.1 million in Q1 2025 and bottomed at -$1.9 million in Q4 2021.
  • The 5-year median for Revenue is $380000.0 (2022), against an average of $497684.2.
  • The largest YoY upside for Revenue was 6925.0% in 2021 against a maximum downside of 485.69% in 2021.
  • A 5-year view of Revenue shows it stood at -$1.9 million in 2021, then grew by 19.79% to -$1.6 million in 2022, then surged by 120.18% to $314000.0 in 2023, then skyrocketed by 373.25% to $1.5 million in 2024, then tumbled by 82.5% to $260000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMDX's Revenue are $260000.0 (Q3 2025), $518000.0 (Q2 2025), and $2.1 million (Q1 2025).